Comments
Pharmaids Pharmaceuticals Limited announced today that it has entered into a loan agreement with Moki Financial Services, a related party, for up to ₹5 crore. The unsecured loan, finalized on September 12, 2024, aims to support working capital requirements, general business purposes, and repayment of existing loans and liabilities.
The shares of Pharmaids Pharmaceuticals Limited were trading at ₹40.11 up by ₹0.99 or 2.53 per cent on the NSE today at 11.40 am.
The loan carries an interest rate of 12 per cent per annum and has a maximum tenure of 5 years from the date of disbursement. Moki Financial Services is considered a related party due to Dr Shankarappa Nagaraja Vinaya Babu, Pharmaids’ Chairman and Non-Executive Director, being a partner in the firm.
The company emphasized that the transaction is conducted at arm’s length. This funding move comes as Pharmaids, a pharmaceutical company based in Bangalore, seeks to strengthen its financial position in the competitive pharmaceutical market.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.